CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II Study of MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02669914
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:06.167088+00:00
Published At: 2018-10-10T00:00:00+00:00
Record Updated At: 2018-11-06
Results Posted At: 2018-10-10
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Non-Small Cell Lung Cancer", "Nonsmall Cell Lung Cancer", "Breast Cancer", "Cancer of Breast", "Cancer of the Breast", "Gastroesophageal Cancer", "Pancreatic Cancer", "Cancer of the Pancreas", "Colorectal Cancer", "Colorectal Carcinoma", "Renal Cancer", "Kidney Cancer", "Cancer of the Kidney", "Cancer of Kidney", "Ovarian Cancer", "Ovary Cancer", "Cancer of the Ovary", "Cancer of Ovary"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-11-06"
protocolSection.identificationModule.nctId: "NCT02669914"
protocolSection.identificationModule.officialTitle: "A Phase II Study of MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2018-10-10"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.